These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12767707)

  • 1. Investigation of the release behavior of a covered-rod-type formulation using silicone.
    Maeda H; Ohashi E; Sano A; Kawasaki H; Kurosaki Y
    J Control Release; 2003 Jun; 90(1):59-70. PubMed ID: 12767707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on accelerated evaluation system for release profiles of covered-rod type silicone formulation using indomethacin as a model drug.
    Maeda H; Sugie T; Sano A; Kawasaki H; Kurosaki Y
    J Control Release; 2004 Feb; 94(2-3):337-49. PubMed ID: 14744485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of controlled-release formulation for ivermectin using silicone.
    Maeda H; Brandon M; Sano A
    Int J Pharm; 2003 Aug; 261(1-2):9-19. PubMed ID: 12878391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drug delivery system for water-soluble drugs using silicone and its usefulness for local treatment: application of GCV-silicone to GCV/HSV-tk gene therapy for brain tumor.
    Maeda M; Moriuchi S; Sano A; Yoshimine T
    J Control Release; 2002 Nov; 84(1-2):15-25. PubMed ID: 12399164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel drug delivery device using silicone: controlled release of insoluble drugs or two kinds of water-soluble drugs.
    Kajihara M; Sugie T; Maeda H; Sano A; Fujioka K; Urabe Y; Tanihara M; Imanishi Y
    Chem Pharm Bull (Tokyo); 2003 Jan; 51(1):15-9. PubMed ID: 12520121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of new drug delivery system for protein drugs using silicone (I).
    Kajihara M; Sugie T; Mizuno M; Tamura N; Sano A; Fujioka K; Kashiwazaki Y; Yamaoka T; Sugawara S; Urabe Y
    J Control Release; 2000 May; 66(1):49-61. PubMed ID: 10708878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of beta-estradiol from biodegradable microparticles within a silicone matrix.
    Brannon-Peppas L
    J Biomater Sci Polym Ed; 1994; 5(4):339-51. PubMed ID: 8025030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined technique based on prilling and microwave assisted treatments for the production of ketoprofen controlled release dosage forms.
    Auriemma G; Del Gaudio P; Barba AA; d'Amore M; Aquino RP
    Int J Pharm; 2011 Aug; 415(1-2):196-205. PubMed ID: 21679754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel method to control release of lipophilic drugs with high potency from silicone.
    Kajihara M; Sugie T; Sano A; Fujioka K; Urabe Y; Tanihara M; Imanishi Y
    Chem Pharm Bull (Tokyo); 2003 Jan; 51(1):11-4. PubMed ID: 12520120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Numerical modelling and experimental investigation of drug release from layered silicone matrix systems.
    Snorradóttir BS; Jónsdóttir F; Sigurdsson ST; Thorsteinsson F; Másson M
    Eur J Pharm Sci; 2013 Jul; 49(4):671-8. PubMed ID: 23684932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient approach to enhance drug solubility by particle engineering of bovine serum albumin.
    Khoder M; Abdelkader H; ElShaer A; Karam A; Najlah M; Alany RG
    Int J Pharm; 2016 Dec; 515(1-2):740-748. PubMed ID: 27832954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of dexibuprofen formulation with fast onset and prolonged effect.
    Choi Y; Min KA; Kim CK
    Drug Dev Ind Pharm; 2019 Jun; 45(6):895-904. PubMed ID: 30889990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation and controlled release of retinol from silicone particles for topical delivery.
    Shields CW; White JP; Osta EG; Patel J; Rajkumar S; Kirby N; Therrien JP; Zauscher S
    J Control Release; 2018 May; 278():37-48. PubMed ID: 29604311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of drug release and tablet characteristics of silicone adhesive matrix tablets.
    Tolia G; Li SK
    Eur J Pharm Biopharm; 2012 Nov; 82(3):518-25. PubMed ID: 22820648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a new drug delivery system for protein drugs using silicone (II).
    Kajihara M; Sugie T; Hojo T; Maeda H; Sano A; Fujioka K; Sugawara S; Urabe Y
    J Control Release; 2001 Jun; 73(2-3):279-91. PubMed ID: 11516505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of silicone pressure-sensitive adhesive episcleral implant for drug delivery.
    Wen H; Li SK
    Drug Dev Ind Pharm; 2016 Jan; 42(1):107-115. PubMed ID: 25923417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microparticles of BSA substituted with deoxycholic acid and triethylene glycol glutarate. Correlations between the physico-chemical properties of the matrix and the release kinetics.
    Orienti I; Gianasi E; Aiedeh K; Zecchi V
    J Pharm Belg; 1996; 51(3):125-30. PubMed ID: 8778345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of branched cationic beta-cyclodextrin polymer/indomethacin complex and its release profile from alginate hydrogel.
    Xin J; Guo Z; Chen X; Jiang W; Li J; Li M
    Int J Pharm; 2010 Feb; 386(1-2):221-8. PubMed ID: 19945520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of protein stability in rod-insert vaginal rings.
    Pattani A; Lowry D; Curran RM; McGrath S; Kett VL; Andrews GP; Malcolm RK
    Int J Pharm; 2012 Jul; 430(1-2):89-97. PubMed ID: 22486955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.